Clinical trial

Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by…

NCT00453388 · Fred Hutchinson Cancer Center, Other · Completed

Key facts

NCT number NCT00453388
Title Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia
Official title Nonmyeloablative Hematopoietic Cell Transplantation for Patients With Fanconi Anemia Using Alternative Marrow Donors: A Phase II Dose-Finding Study
Lead sponsor Fred Hutchinson Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH National Heart, Lung, and Blood Institute (NHLBI)
Status Completed
Phase Phase 2
Study type Interventional
Conditions Acute Myeloid Leukemia in Remission, de Novo Myelodysplastic Syndrome, Fanconi Anemia, Previously Treated Myelodysplastic Syndrome
Intervention type Drug, Other, Procedure, Radiation
Interventions Allogeneic Bone Marrow Transplantation, Cyclophosphamide, Cyclosporine, Fludarabine Phosphate, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation, Total-Body Irradiation
Enrollment 6
Start date Feb 1, 2007
Primary completion Jun 1, 2013
Completion Jun 1, 2013
First posted Mar 28, 2007
Last update posted Jan 29, 2020
Countries Brazil, United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies